The primary objective of this study is to evaluate the pharmacokinetic profile of a single dose of intravenous ibuprofen administered over approximately ten (10) minutes.
||Interventional (Clinical Trial)
||Single Group Assignment
||None (Open Label)
||A Multi-Center, Open-Label Pharmacokinetic and Safety Study for Reduction in Fever or Management of Pain in Pediatric Subjects Aged Birth to Six Months
|Actual Study Start Date:
||July 17, 2017
|Estimated Primary Completion Date:
|Estimated Study Completion Date:
|Contact: Byron Kaelin
||615-255-0068 ext 250
|Contact: Jerry Fox
||615-255-0068 ext 226
For enrollment please visit www.clinicaltrials.gov.